193 related articles for article (PubMed ID: 15597147)
1. Drotrecogin alfa (activated) inhibits NF-kappa B activation and MIP-1-alpha release from isolated mononuclear cells of patients with severe sepsis.
Brueckmann M; Hoffmann U; Dvortsak E; Lang S; Kaden JJ; Borggrefe M; Haase KK
Inflamm Res; 2004 Oct; 53(10):528-33. PubMed ID: 15597147
[TBL] [Abstract][Full Text] [Related]
2. Activated protein C inhibits the release of macrophage inflammatory protein-1-alpha from THP-1 cells and from human monocytes.
Brueckmann M; Hoffmann U; De Rossi L; Weiler HM; Liebe V; Lang S; Kaden JJ; Borggrefe M; Haase KK; Huhle G
Cytokine; 2004 May; 26(3):106-13. PubMed ID: 15135804
[TBL] [Abstract][Full Text] [Related]
3. Effect of drotrecogin alfa (activated) on human endothelial cell permeability and Rho kinase signaling.
Zeng W; Matter WF; Yan SB; Um SL; Vlahos CJ; Liu L
Crit Care Med; 2004 May; 32(5 Suppl):S302-8. PubMed ID: 15118535
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance.
Adib-Conquy M; Adrie C; Moine P; Asehnoune K; Fitting C; Pinsky MR; Dhainaut JF; Cavaillon JM
Am J Respir Crit Care Med; 2000 Nov; 162(5):1877-83. PubMed ID: 11069829
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human activated protein C upregulates cyclooxygenase-2 expression in endothelial cells via binding to endothelial cell protein C receptor and activation of protease-activated receptor-1.
Brueckmann M; Horn S; Lang S; Fukudome K; Schulze Nahrup A; Hoffmann U; Kaden JJ; Borggrefe M; Haase KK; Huhle G
Thromb Haemost; 2005 Apr; 93(4):743-50. PubMed ID: 15841323
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 inhibits proinflammatory chemokine release by neutrophils of the newborn without suppression of nuclear factor-kappa B.
Tryzmel J; Miskolci V; Castro-Alcaraz S; Vancurova I; Davidson D
Pediatr Res; 2003 Sep; 54(3):382-6. PubMed ID: 12788980
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of platelet-derived growth factor in patients with severe sepsis.
Brueckmann M; Hoffmann U; Engelhardt C; Lang S; Fukudome K; Haase KK; Liebe V; Kaden JJ; Putensen C; Borggrefe M; Huhle G
Growth Factors; 2007 Feb; 25(1):15-24. PubMed ID: 17454146
[TBL] [Abstract][Full Text] [Related]
8. Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis.
Dhainaut JF; Yan SB; Margolis BD; Lorente JA; Russell JA; Freebairn RC; Spapen HD; Riess H; Basson B; Johnson G; Kinasewitz GT;
Thromb Haemost; 2003 Oct; 90(4):642-53. PubMed ID: 14515185
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappaB.
Joyce DE; Grinnell BW
Crit Care Med; 2002 May; 30(5 Suppl):S288-93. PubMed ID: 12004250
[TBL] [Abstract][Full Text] [Related]
10. [Severe sepsis treated with activated protein C].
Frøyshov S; Jacobsen D; Bjertnaes L; Flaatten H
Tidsskr Nor Laegeforen; 2004 Mar; 124(6):779-81. PubMed ID: 15039807
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human activated protein C resets thrombin generation in patients with severe sepsis - a case control study.
de Pont AC; Bakhtiari K; Hutten BA; de Jonge E; Vroom MB; Meijers JC; Büller HR; Levi M
Crit Care; 2005 Oct; 9(5):R490-7. PubMed ID: 16277710
[TBL] [Abstract][Full Text] [Related]
12. Comment on "Drotrecogin Alfa (activated) (recombinant human protein C, rhAPC) reduces host coagulopathy response in patients with severe sepsis".
Taylor F
Thromb Haemost; 2003 Oct; 90(4):560-1. PubMed ID: 14515171
[No Abstract] [Full Text] [Related]
13. Influence of drotrecogin alpha (activated) infusion on the variation of Bax/Bcl-2 and Bax/Bcl-xl ratios in circulating mononuclear cells: a cohort study in septic shock patients.
Bilbault P; Lavaux T; Launoy A; Gaub MP; Meyer N; Oudet P; Pottecher T; Jaeger A; Schneider F
Crit Care Med; 2007 Jan; 35(1):69-75. PubMed ID: 17133181
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of chroman carboxamide on interleukin-6 expression in response to lipopolysaccharide by preventing nuclear factor-kappaB activation in macrophages.
Kim BH; Lee KH; Chung EY; Chang YS; Lee H; Lee CK; Min KR; Kim Y
Eur J Pharmacol; 2006 Aug; 543(1-3):158-65. PubMed ID: 16797005
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
[TBL] [Abstract][Full Text] [Related]
17. Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis.
Zheng W; Li R; Pan H; He D; Xu R; Guo TB; Guo Y; Zhang JZ
Arthritis Rheum; 2009 Jul; 60(7):1957-65. PubMed ID: 19565503
[TBL] [Abstract][Full Text] [Related]
18. Glimepiride reduces mononuclear activation of the redox-sensitive transcription factor nuclear factor-kappa B.
Schiekofer S; Rudofsky G; Andrassy M; Schneider J; Chen J; Isermann B; Kanitz M; Elsenhans S; Heinle H; Balletshofer B; Häring HU; Schleicher E; Nawroth PP; Bierhaus A
Diabetes Obes Metab; 2003 Jul; 5(4):251-61. PubMed ID: 12795658
[TBL] [Abstract][Full Text] [Related]
19. Relation of signal in mononuclear cell with endotoxin response and clinical outcome after trauma.
Shih HC; Huang MS; Lee CH
Am J Emerg Med; 2012 Mar; 30(3):405-11. PubMed ID: 21296525
[TBL] [Abstract][Full Text] [Related]
20. Increased nuclear factor-kappaB activation in peripheral blood monocytes of patients with rheumatoid arthritis is mediated primarily by tumor necrosis factor-alpha.
Dichamp I; Bourgeois A; Dirand C; Herbein G; Wendling D
J Rheumatol; 2007 Oct; 34(10):1976-83. PubMed ID: 17896809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
